bpc 157 selfhacked BPC-157 BPC-157 (Body Protection Compound-157) is

Additionally, about 10% to 15% of patients who have neurological symptoms and who start on chelation therapy develop a paradoxical worsening of their neurological disease

Main Street, Unit 203 Littleton, CO 80120 Phone (720) 582-2436 Call or Text Hours Mon-Fri: 10am - 6pm Saturday: 10am - 4pm Sunday: 9am - 1pm Parking Street parking available on Main Street

Hauser, P

Linder P

Pre-Blend Weekly Schedule Example Pre-blend dose at each titration step Phase Start Weeks 1-4 Draw Volume 0.40 mL (40 units) Reta Delivered 2.0 mg Cag Delivered 0.4 mg Phase Step 1 Weeks 5-8 Draw Volume 0.60 mL (60 units) Reta Delivered 3.0 mg Cag Delivered 0.6 mg Phase Step 2 Weeks 9-16 Draw Volume 0.80 mL (80 units) Reta Delivered 4.0 mg Cag Delivered 0.8 mg Phase Step 3 Weeks 17-20 Draw Volume 1.20 mL (120 units) Reta Delivered 6.0 mg Cag Delivered 1.2 mg Phase Step 4 Weeks 21-24 Draw Volume 1.60 mL (160 units) Reta Delivered 8.0 mg Cag Delivered 1.6 mg Phase Maintenance Weeks 25+ Draw Volume 2.40 mL (240 units) Reta Delivered 12.0 mg Cag Delivered 2.4 mg One injection per week

All findings referenced in publicly available literature relate exclusively to laboratory research settings